{"id":232978,"date":"2026-04-11T23:20:51","date_gmt":"2026-04-12T03:20:51","guid":{"rendered":"https:\/\/www.midwest-brokers.com\/medical-practice-valuation-indiana-what-practitioners-should-know-before-selling-to-a-group\/"},"modified":"2026-08-25T18:00:47","modified_gmt":"2026-08-25T22:00:47","slug":"valoracion-de-practicas-medicas-indiana-lo-que-los-profesionales-deben-saber-antes-de-vender-a-un-grupo","status":"publish","type":"post","link":"https:\/\/www.midwest-brokers.com\/es\/medical-practice-valuation-indiana-what-practitioners-should-know-before-selling-to-a-group\/","title":{"rendered":"Valoraci\u00f3n de Pr\u00e1cticas M\u00e9dicas en Indiana: Lo que los Profesionales Deben Saber Antes de Vender a un Grupo"},"content":{"rendered":"

Most physicians start in the wrong place. They ask what multiple medical practices sell for, or what percentage of revenue a hospital or private equity-backed group will pay. That is understandable, but it is not how serious buyers underwrite a practice in Indiana. They do not buy your gross charges. They do not buy the legend you have told yourself about loyalty. They do not buy the version of earnings that exists only because you own the place and work harder than a replacement physician would. They buy durable cash flow after provider replacement, after payer friction, after compliance review, and after the staff and patients react to a new name on the door.<\/p>\n

That is why a medical practice valuation can move by seven figures without the top line changing very much. A $6 million multi-provider practice with a disciplined revenue cycle, stable employed physicians, defendable ancillaries, and a clean lease can produce a very different outcome from a $6 million practice where one rainmaker controls the referrals, 90-day accounts receivable are piling up, and every important relationship still runs through the founder’s cell phone.<\/p>\n

Indiana geography adds another layer. Census QuickFacts shows Hamilton County at 387,036 residents as of July 1, 2025, up 11.4% from the 2020 base, with median household income of $121,530 in 2020-2024 data and $3.65 billion in 2022 health care and social assistance receipts. Marion County is the scale market, with 992,196 residents as of July 1, 2025, $17.01 billion in 2022 health care receipts, and 24,248 employer establishments in 2023. Allen County gives buyers a strong Fort Wayne regional-hub story at 402,329 residents, $6.23 billion in health care receipts, and 9,696 employer establishments. Vanderburgh County remains a meaningful southern Indiana healthcare market at 181,995 residents and $3.02 billion in health care receipts. Buyers do not ignore those facts. They use them to decide whether your future growth is believable.<\/p>\n

The Indiana market, as of April 11, 2026, still has real demand for quality physician practices, but it is selective demand. Hospital systems are careful because physician compensation, Stark Law, and site-of-service strategy all matter. PE-backed groups are careful because rates are not cheap, platform buyers want add-ons that actually integrate, and nobody wants to overpay for revenue that disappears when one doctor leaves. If you want a clean starting point before you test the market, begin with a Professional Valuation Assessment<\/a>.<\/p>\n

There is another point most owners miss until the first indication of interest arrives: enterprise value is not the same thing as what you keep. Debt payoff, taxes, working-capital expectations, employment terms, rollover equity, and the broker’s success fee all change the real outcome. Midwest Business Brokers works in the $1 million to $10 million lane and uses the Double Lehman Scale: 10% on the first $1 million, 8% on the second, 6% on the third, 4% on the fourth, and 2% above $4 million. Serious sellers care about net proceeds and deal certainty, not just the headline number.<\/p>\n

The rest of this article is the buyer’s lens. Not a generic healthcare consultancy memo and not a compliance treatise. This is how hospital systems, PE-backed medical groups, lenders, and experienced M&A advisors actually price medical practices in Indiana when a qualified seller is trying to exit to a group.<\/p>\n

What Indiana Medical Practices Actually Sell For in 2026<\/h2>\n

The first honest answer is that Indiana medical practices do not trade on one universal formula. Smaller, owner-centric practices still get discussed in rough revenue terms because compensation is distorted and buyers are trying to solve for replacement economics. Larger groups with multiple employed providers, real ancillaries, and credible management depth get valued on adjusted EBITDA. The jump from one framework to the other is not cosmetic. It is the moment when your practice stops being a job with goodwill and starts being a transfer-ready operating business.<\/p>\n\n\n\n\n\n\n\n\n
Practice profile<\/th>\nHow buyers usually frame value<\/th>\nIndicative Indiana range<\/th>\nWhat moves the range<\/th>\n<\/tr>\n<\/thead>\n
Solo primary care or internal medicine practice with $1.2M-$2.5M revenue and heavy owner dependence<\/td>\nRevenue multiple cross-checked to replacement-doctor cash flow<\/td>\nRoughly 0.45x-0.70x revenue or 3.5x-4.5x adjusted EBITDA<\/td>\nPayer mix, provider replacement cost, panel stability, lease terms, and recruiting difficulty<\/td>\n<\/tr>\n
Multi-provider family, pediatric, or specialty practice with $2.5M-$6.0M revenue<\/td>\nAdjusted EBITDA with revenue used only as a reasonableness check<\/td>\nAbout 4.5x-6.0x adjusted EBITDA<\/td>\nEmployed provider retention, ancillaries, county growth, collections quality, and management depth<\/td>\n<\/tr>\n
Specialty group with meaningful ancillaries and EBITDA above $1M<\/td>\nInstitutional EBITDA model<\/td>\nAbout 5.5x-7.0x adjusted EBITDA, sometimes higher for strong strategic fits<\/td>\nScalable earnings, procedure mix, compliance discipline, and whether the buyer can roll the practice into a regional platform<\/td>\n<\/tr>\n
Rural or small-market practice where one physician still controls most referrals and production<\/td>\nLower-end EBITDA or revenue framework with financing reality check<\/td>\nOften 3.0x-4.25x adjusted EBITDA and sometimes below 0.50x revenue<\/td>\nRecruiting risk, county demographics, stale A\/R, thin support staff bench, and weaker post-close transferability<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Those are not public-exchange multiples because physician practice deals in this size band are not publicly quoted the way large-cap stocks are. They are market ranges based on how real buyers and lenders solve for transferability. The exact number lives inside the details. If your practice has two employed physicians under clean agreements, a nurse practitioner bench that actually produces, and payer contracts that support the revenue, you will live near the upper half of the range. If one physician produces half the EBITDA and wants to retire the day after closing, you will not.<\/p>\n

County-level demand affects those ranges more than owners like to admit. Hamilton County gives buyers a growth story, recruiting appeal, and commercial-payor depth. Marion County gives scale, density, and a large health-system footprint. Allen County supports Fort Wayne as a regional hub for specialty services. In weaker-growth or smaller rural markets, buyers will still transact, but they pay for demonstrated stability rather than projected upside. That is why a general Indiana business valuation<\/a> framework still matters even in a regulated industry: the market is always pricing durability.<\/p>\n

Financing also sets a floor under what individual buyers and smaller group buyers can pay and, as of April 11, 2026, prime still sat at 6.75%, while the SBA maximum variable rate on most larger 7(a) loans was still 9.75%. A $2.7 million acquisition note amortized over 10 years at 9.75% carries annual principal and interest of about $423,696. At a 1.25x debt-service coverage requirement, that means roughly $529,620 of dependable post-replacement cash flow just to clear lender math. Even if your likely buyer is a hospital or PE-backed group, that financeability backdrop influences the broader market’s sense of value.<\/p>\n

Now look at the seller side. A $5.8 million enterprise value sounds clean until you run the fee math and structure math. Under the Double Lehman Scale, Midwest Business Brokers’ fee on $5.8 million is $316,000: $100,000 on the first million, $80,000 on the second, $60,000 on the third, $40,000 on the fourth, and $36,000 on the final $1.8 million. If the deal also includes debt payoff, a working-capital true-up, and a retained equity piece, the gap between headline value and real liquidity gets large in a hurry. Sellers who understand that upfront negotiate better.<\/p>\n

Hospital Systems vs PE-Backed Groups: How Each Values Your Practice<\/h2>\n

Owners love asking whether hospitals or private equity pay more. That is the wrong first question. The right question is which buyer type likes the exact practice you own and how that buyer expresses value. A hospital system may put the highest cash-at-close number on a primary care group that fills a geographic coverage gap. A PE-backed platform may put the highest multiple on a specialty practice with repeatable EBITDA, ancillaries, and a provider bench that can be scaled across a region. Those are not the same practice, and they are not the same kind of bid.<\/p>\n

\"medical<\/figure>\n\n\n\n\n\n\n\n\n\n
Issue<\/th>\nHospital system lens<\/th>\nPE-backed group lens<\/th>\n<\/tr>\n<\/thead>\n
Primary value driver<\/td>\nStrategic coverage, physician alignment, service-line access, and referral leakage control<\/td>\nAdjusted EBITDA, platform fit, density in the region, and margin expansion opportunity<\/td>\n<\/tr>\n
Favorite target<\/td>\nPractice that strengthens a geographic footprint or fills a specialty need<\/td>\nMulti-provider practice that can bolt into an existing platform without the founder running every decision<\/td>\n<\/tr>\n
What earns a premium<\/td>\nClean compliance, strong commercial panel, local physician loyalty, and strategic scarcity<\/td>\nDocumented growth, transferable ancillaries, recruiting depth, and standardized operations<\/td>\n<\/tr>\n
What gets punished<\/td>\nReferral-sensitive side deals, provider turnover risk, and shaky compensation structure<\/td>\nThin margins, owner dependence, bad data, and revenue that dies with one departing physician<\/td>\n<\/tr>\n
Typical structure<\/td>\nCash at close plus employment, call coverage terms, and system integration requirements<\/td>\nCash at close plus rollover equity, retention economics, earn-out, or longer-term employment commitments<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Hospital systems usually think in terms of strategic utility before they think in terms of pure multiple. If your practice helps them anchor a county, keep admissions and downstream services in-network, or solve an access problem in a specialty they cannot recruit fast enough, the hospital can justify paying for more than just trailing earnings. That can work in the seller’s favor, especially in primary care, cardiology, orthopedics, women’s health, and other specialties where geographic coverage matters. It can also come with heavier diligence, slower governance, and more attention to fair market value and compensation support.<\/p>\n

PE-backed groups are less sentimental and more formulaic, which is not always a bad thing. They usually care most about the normalized EBITDA that survives after founder dependence is stripped out, what the provider roster looks like two years from now, whether the platform can improve scheduling or revenue cycle, and whether the practice fills in a regional map. If your group has three productive employed physicians, a stable administrator, good reporting, and a repeatable ancillary mix, institutional buyers can be aggressive because they are buying a unit that fits an existing system.<\/p>\n

The biggest mistake sellers make is comparing headline values instead of economic reality. A hospital may offer $6.1 million cash at close but tie the doctor employment package to conservative productivity assumptions. A PE-backed group may offer $6.5 million with 70% cash, 20% rollover, and 10% linked to retention. Which one is better depends on the seller’s goals, risk tolerance, and the credibility of the post-close plan. If you still blur owner pay, personal perks, and actual operating earnings together, read SDE vs EBITDA explained<\/a> before you start weighing letters of intent.<\/p>\n

Here is a simple example. Assume a four-provider specialty practice generates $1.2 million of adjusted EBITDA. A PE-backed group might pay 6.25x, or $7.5 million, if all four providers are under long-term agreements and ancillaries are clean. A hospital system that does not need the service line or already has coverage in the county may stay closer to 5.5x, or $6.6 million. Flip the facts. Suppose the practice is lower-margin primary care in a county where the hospital has an access problem and wants to stop downstream referral leakage. The hospital may now be the premium payer, while PE loses interest because the margin story is thin. That is why the generic question, “Who pays more?” is not useful.<\/p>\n

The right pre-sale work is to identify which buyer thesis your practice supports, then package the business in that language. Strategic buyers want access, alignment, and service-line logic. Institutional buyers want scale, repeatability, and documented EBITDA. Sellers who mix those stories together usually underperform with both audiences.<\/p>\n

Revenue Quality: Payer Mix, Collections, and Accounts Receivable<\/h2>\n

Revenue quality is where physician practice valuation stops being a vanity exercise and starts becoming a finance exercise. Buyers do not care what you billed if the money does not come in cleanly. They care about what you collect, how predictable those collections are, how exposed you are to one payor category, how quickly claims convert to cash, and how much work the buyer will have to do to fix the cycle after closing.<\/p>\n

Take two Indiana practices with the same $6.2 million in gross charges. Practice A collects $4.45 million on a payer mix of 52% commercial, 28% Medicare, 12% Medicaid, and 8% self-pay. Days in A\/R sit at 38, denials are controlled, and only 11% of receivables are older than 90 days. Practice B collects $3.96 million on a mix of 34% commercial, 24% Medicare, 30% Medicaid, and 12% self-pay, with 57 days in A\/R and 19% of receivables older than 90 days. If Practice A produces $930,000 of adjusted EBITDA and Practice B produces $610,000, a 5.5x multiple creates a $1.76 million value gap from revenue quality alone. Same charges. Very different value.<\/p>\n

This is where payer mix matters. Commercial-heavy revenue is not automatically superior if the contracts are weak, but it usually supports a stronger reimbursement profile and easier underwriting than a panel skewed toward low-paying managed Medicaid or chronically difficult self-pay collections. Medicare has predictability but not always pricing power. Medicaid can be strategically important, especially in pediatrics, family medicine, behavioral health, and some multispecialty settings, but buyers will underwrite the operational burden alongside the revenue.<\/p>\n

Indiana Medicaid adds real complexity. The Indiana Health Coverage Programs say the state works with six managed care health plans across HIP, Hoosier Care Connect, Hoosier Healthwise, and PathWays, and those partners handle network development, contracting and credentialing, claim processing, utilization management, and provider outreach. That means a Medicaid-heavy practice is not just selling patient volume. It is selling a contract-management and credentialing machine. If your staff cannot show low denial rates, timely renewals, and disciplined eligibility verification, buyers assume margin leakage.<\/p>\n

Accounts receivable tells the same story from a different angle. Hospital systems often exclude A\/R from the enterprise-value multiple and purchase it separately, or they build a working-capital peg that effectively forces the seller to leave normal receivables behind. PE-backed groups usually do a more detailed aging review and haircut stale balances aggressively. If 20% of your A\/R is older than 120 days, the buyer is not going to pay full multiple credit for it. They will either discount the working-capital assumption or normalize your revenue downward on the theory that your billing operation is overstating realizable value.<\/p>\n

Owners also get lazy with collection ratio analysis. They like to defend weak net collections by pointing to specialty mix or “Indiana reimbursement realities.” Serious buyers do not accept that at face value. They want provider-level productivity, CPT mix, denial trends, write-off policies, and evidence that the practice has actually been managed rather than tolerated. If you are about to sell, get those schedules into shape before the first buyer asks. Once the buyer finds the weak spot first, you are no longer negotiating from strength.<\/p>\n

Provider Retention: The Single Biggest Variable in Your Exit<\/h2>\n

If you want the shortest answer to what moves a medical practice valuation up or down, here it is: provider retention. Not logo. Not furniture. Not website. Not the owner’s reputation at the country club. The providers who stay, the providers who can be recruited, and the providers whose patient relationships can survive a transaction. That is the center of gravity in almost every physician practice sale above the very small end of the market.<\/p>\n

\"Indiana<\/figure>\n

Run the math on a typical lower-middle-market group. Assume a four-provider specialty practice generates $8.4 million in revenue and $1.15 million in adjusted EBITDA. One physician accounts for $2.2 million of revenue and does not have a binding long-term employment agreement. The buyer models a 35% patient attrition risk if that doctor leaves, plus $420,000 of recruiting, sign-on, and locum coverage cost. Adjusted EBITDA drops from $1.15 million to roughly $720,000. At 6.0x EBITDA, value falls from $6.9 million to $4.32 million. That is $2.58 million of value lost because one provider relationship was not nailed down before the sale process started.<\/p>\n

The same logic applies to the seller-physician. Buyers do not expect every founder to stay forever, but they absolutely underwrite the transition. Six to twelve months of visible handoff, patient messaging, chart transition, and provider overlap usually protects value better than a vague promise to be “available if needed.” If the selling physician wants to disappear at closing, the buyer will either discount the offer, shift money into contingent consideration, or demand heavier retention economics for the remaining clinical team.<\/p>\n

Hospitals and PE-backed groups both care about more than doctors. They care about nurse practitioners, physician assistants, lead MAs, office administrators, coding supervisors, referral coordinators, and revenue-cycle leaders. In a physician practice, those people often hold the operating memory of the business. A buyer who loses the billing manager, the referral nurse, and two employed physicians in the first 90 days has not bought a stable platform. They have bought a repair project.<\/p>\n

This is why physician employment agreements, compensation models, notice periods, and restrictive-covenant enforceability should be cleaned up before the data room opens. The market will forgive a lot, but it does not forgive avoidable provider instability. If your group has key contracts that have not been reviewed in years, or if you are not sure how a buyer will read your provider concentration risk, Schedule Your Confidential Consultation<\/a> before you circulate numbers. That conversation is cheaper before the first indication of interest than after the first retrade.<\/p>\n

Stark Law and Anti-Kickback Considerations in Physician Sales<\/h2>\n

This is the section where bad structure turns a good economic deal into an expensive legal mess. If a buyer is effectively paying above fair market value because your referrals will feed its hospital, imaging center, lab, or surgery business, that is not clever structuring. That is risk. Serious healthcare buyers know it. Sophisticated sellers should know it too.<\/p>\n

CMS’s Stark Law framework prohibits physician referrals for designated health services to an entity with which the physician has a financial relationship unless an exception applies. For one-time physician practice sales, the most relevant concept is often the isolated transaction exception in 42 CFR 411.357(f). The current rule says compensation in an isolated transaction must be consistent with fair market value, not determined in a manner that takes into account the volume or value of referrals, and provided under an arrangement that would be commercially reasonable even if no referrals were made. It also limits additional transactions between the parties for six months after closing, except for transactions that fit other exceptions and commercially reasonable post-closing adjustments that do not reflect referrals.<\/p>\n

That matters because sellers routinely agree to side arrangements without thinking through how they will be viewed together. Employment comp. Medical director pay. Call coverage. Lease terms in the medical office building. Equipment rental. Co-management. EHR support. Buyers and counsel do not look at those items in isolation. They look at the total economics between the parties and ask whether the combined package still reads as fair market value.<\/p>\n

The Anti-Kickback Statute is different and, in some ways, harsher. HHS OIG said in a 2024 FAQ that compliance with a safe harbor is voluntary and failure to satisfy a safe harbor does not automatically make an arrangement illegal, but satisfying Stark does not automatically protect you under AKS either. OIG was explicit that an arrangement can fit a Stark exception and still violate AKS depending on the facts and intent. That is the point too many physician sellers miss when they assume a hospital or platform buyer will “handle the compliance side.”<\/p>\n

Common danger areas in practice sales are not mysterious. A purchase price that only makes sense if the seller keeps referring DHS after the sale. Above-market rent on space the buyer still needs. Compensation formulas that quietly reward ancillaries rather than personal productivity. Management fees that have no defensible fair market value analysis behind them. Earn-outs tied to downstream referral patterns instead of legitimate operating performance. None of that is theoretical. It is where healthcare deals get slowed, re-papered, or repriced.<\/p>\n

There are safe harbors and exceptions for common post-close arrangements such as office-space leases, equipment leases, personal services contracts, and EHR items and services, but each has detailed conditions. The practical rule is simple: if part of your price story depends on post-close relationships with the buyer, get healthcare regulatory counsel and fair-market-value support involved early. The broader process work in the 2026 ultimate seller guide<\/a> still applies, but physician practice deals need another layer of discipline.<\/p>\n

Ancillary Revenue: Imaging, Labs, In-Office Procedures<\/h2>\n

Ancillary revenue can meaningfully increase value, but only when it is profitable, transferable, and compliant. Owners like to say, “We have imaging and lab in-house,” as though that sentence alone creates a premium. It does not. The buyer wants to know whether the ancillary line actually contributes margin, whether utilization is defensible, whether supervision and documentation are clean, whether payor contracts recognize the service, and whether the revenue survives when the current physicians are no longer calling every shot.<\/p>\n

Consider a $5.6 million specialty practice with $840,000 of core practice EBITDA and another $260,000 from imaging, lab, and in-office procedures. If all of that ancillary EBITDA is well documented, spread across multiple providers, and consistent with the practice’s clinical model, a buyer valuing the platform at 6.0x could justify about $6.6 million. Now change the facts. Suppose $120,000 of the ancillary EBITDA depends almost entirely on one selling physician’s ordering pattern and another $80,000 looks thin under coding or utilization review. The buyer may only credit $60,000 to $100,000 of that ancillary margin. That alone can wipe out roughly $960,000 to $1.2 million of enterprise value.<\/p>\n

Hospitals and PE-backed groups read ancillaries differently. A hospital may value imaging or procedures that fit an existing service-line strategy, but it will be highly sensitive to Stark and compensation interactions. A PE-backed group usually focuses first on margin, throughput, coding discipline, and whether the ancillary line can be replicated across locations. In both cases, the premium comes from transferability, not from the seller’s enthusiasm.<\/p>\n

Not all ancillary revenue deserves the same multiple. An in-office procedure line supported by multiple clinicians, clean scheduling, clear documentation, and durable demand is much more valuable than a niche procedure line that one founder performs three half-days a month. The same applies to lab and imaging. Buyers pay full freight for systems. They discount physician-specific habits.<\/p>\n

If you want to defend ancillary value, be prepared to show profitability by service line, utilization by provider, payor performance, equipment uptime, referral sources, and compliance support. If you cannot produce that quickly, buyers assume the line is weaker than management claims. They are often correct.<\/p>\n

EHR, Tech Stack, and Operational Efficiency<\/h2>\n

Technology does not create value on its own, but weak systems destroy value constantly. In physician-practice deals, the EHR and revenue-cycle stack are not back-office details. They are the buyer’s proof of whether management actually knows the business. If your EHR can produce provider-level productivity, payer mix by location, days-to-third-next-available appointment, no-show rates, visit counts by CPT family, and referral leakage reports in minutes, the buyer relaxes. If your team needs two weeks and three spreadsheets to answer basic diligence questions, the buyer assumes the operation is fragile.<\/p>\n

Operational efficiency matters because buyers are pricing not just earnings, but the cost to integrate and improve the practice. A hospital wants to know how painful it will be to move the site into a system workflow. A PE-backed group wants to know whether billing, scheduling, intake, prior authorization, and patient communication can be standardized across a larger platform. Clean dashboards, disciplined templates, and basic KPI visibility support value because they reduce post-close friction.<\/p>\n

There is also a regulatory angle. Current Stark and AKS rules include exceptions and safe-harbor protection for certain electronic health record items and services, but they are not free-for-all subsidies. The Stark EHR exception requires interoperable software, a written agreement, and a physician contribution equal to 15% of the donor’s cost. AKS safe-harbor protection around EHR and cybersecurity support has similar structure and documentation requirements. If part of your integration story depends on a buyer helping fund or replace your tech, that support must be papered properly.<\/p>\n

Cybersecurity and data governance now matter more than many independent groups still realize. A buyer who sees poor user-permission controls, weak documentation of vendor oversight, or no coherent incident-response process is not just worried about IT. They are worried about reputational risk, post-close cleanup cost, and management discipline. In a professional practice sale, operational sloppiness is never confined to one department.<\/p>\n

The practical takeaway is simple. Before the sale process starts, know which reports your system can produce, clean up the ones that matter, and test whether the team can deliver them under time pressure. That work is boring. It is also profitable.<\/p>\n

Real Estate and Medical Office Building Considerations<\/h2>\n

Medical real estate is one of the easiest places for sellers to confuse asset value with operating value. The building may be important, but the practice should still be priced as a practice. If you own the medical office building and charge yourself below-market rent, buyers will normalize rent upward before they value EBITDA. If you charge yourself above-market rent because you want more cash flow in the real estate entity, buyers will normalize it downward. Either way, the market is going to reset the number.<\/p>\n

Take a simple example. Your practice occupies 8,000 square feet and currently pays a related-party rent equivalent to $15 per square foot. The market for comparable medical space says $24 per square foot is more realistic. That is a $72,000 annual EBITDA adjustment. At 5.5x EBITDA, the value impact is roughly $396,000. That change has nothing to do with patient care and everything to do with whether your numbers reflect market economics.<\/p>\n

Lease structure matters too. Buyers want term, renewal options, assignment rights, clear responsibility for CAM and capital items, and rent that can be defended as fair market value. That is not only economics. It is also compliance. The Stark and AKS rules for office-space leases and equipment rentals both require written agreements, a term of at least one year, compensation set in advance, fair-market-value economics, and no referral-based pricing. If the practice sale is followed by a leaseback or continued occupancy arrangement, sloppy documents can create immediate diligence drag.<\/p>\n

Rate conditions also matter in 2026. Even though this article is about selling to groups, the broader buyer universe still feels the lending market. A $2.7 million 10-year note at 9.75% carries annual debt service of about $423,696. At 1.25x debt-service coverage, that implies about $529,620 of dependable cash flow. If the practice and real estate are bundled into a structure that blows past what the next-best buyer could reasonably finance, you may have narrowed your own market without realizing it.<\/p>\n

For many Indiana physician sellers, the best answer is to separate the economics clearly. Value the practice on normalized operating earnings. Value the building on market rent and real estate fundamentals. Then decide whether the best buyer needs both, only the practice, or the practice with a long-term lease. Blurring the categories creates financing problems that sellers often mistake for valuation problems.<\/p>\n

Indiana Medicaid, IU Health, and Ascension Buyer Dynamics<\/h2>\n

This is where Indiana stops looking like a generic healthcare market. State Medicaid mechanics, local system footprints, and county-level demand all shape what buyers will pay and how they structure the deal. If you ignore those variables, you are not really pricing an Indiana medical practice. You are pricing a fantasy practice in a generic spreadsheet.<\/p>\n

Start with Indiana Medicaid. The state’s provider-enrollment guidance is clear that a change of ownership is treated as a new enrollment rather than a simple profile update. The IHCP says business-profile changes generally must be reported within 10 business days, but a true CHOW requires a fresh enrollment package, supporting documentation, and proof of the ownership transaction such as a purchase agreement or bill of sale. Revalidation intervals cannot exceed five years for most providers, and the state says providers receive 60-day and 30-day notices before revalidation deadlines. If an application fee applies, Indiana says the 2026 amount is $750 per service location. That may not be a big check in a $5 million deal, but it is exactly the kind of detail that can slow reimbursement if nobody owns it.<\/p>\n

Now look at the system side. IU Health describes itself as the largest network of physicians in Indiana and says it operates 15 hospitals with a unified medical group, about 39,000 team members, and more than 600 sites of care. A system that large does not evaluate your practice like a solo buyer would. It is asking where you fit in regional coverage, which service lines you strengthen, how your providers align with the system, and whether the revenue can be integrated without creating a compliance headache.<\/p>\n

Ascension St. Vincent is just as relevant to the buyer map. Ascension’s Indiana pages say the system operates 19 hospitals and two children’s hospitals in the state, and its 2024 Indiana implementation-strategy documents say Ascension St. Vincent employs more than 13,000 associates statewide. That matters because the St. Vincent footprint spans Indianapolis, the north suburbs, central Indiana, and the Evansville area. Sellers in those corridors are often not negotiating against an abstract “hospital market.” They are negotiating inside a real strategic footprint.<\/p>\n

The county data explains why the same specialty can price differently in different Indiana markets. Hamilton County offers affluent suburban growth and strong employer density. Marion County offers scale and a massive healthcare ecosystem. Allen County gives buyers a Fort Wayne regional-hub platform with more than $6.22 billion in health care receipts. Vanderburgh County remains strategically important because it anchors a southern Indiana market with more than $3.01 billion in health care receipts and strong system presence. Buyers build recruiting, access, and growth assumptions directly from those realities.<\/p>\n

PE-backed groups read the map differently, but they read it. They like Indianapolis and the north-suburban corridor because add-on density is easier to create. They like Fort Wayne because Allen County supports a regional-hub story without Indianapolis competition levels. They like Evansville and other secondary markets when a platform can gain coverage without paying top-tier metro pricing. What they do not like is a practice that depends on one physician in a county where replacement recruiting is a three-alarm problem.<\/p>\n

That is the practical Indiana picture as of April 11, 2026. Medicaid-heavy practices need enrollment and managed-care discipline. Practices in major system corridors need to understand local strategic demand, not just national roll-up chatter. And every physician owner considering a sale to a group needs to know which local buyer logic applies before the process starts.<\/p>\n

Exit Playbook: 18 Months of Prep That Protects Value<\/h2>\n

Eighteen months is enough time to improve value if the fundamentals are sound. It is not enough time to fake a transferable business. The physicians who get paid best are usually the ones who use that window to remove buyer objections before the market sees them.<\/p>\n

Start with the numbers, then move to transferability, then move to structure. That order matters. If you begin with marketing and skip the cleanup, the buyer will find the weak spots for you. The better sequence is to get the financial picture right, document the provider and ancillary story, clean the compliance file, and then decide which buyer audience you are really targeting.<\/p>\n